Effect of the resistin -420C > G polymorphism on cardiovascular disease and mortality

Clinical Endocrinology

Volumn 69, Issue 2, 2008, Pages 344-345

  Hoffmann, Michael M ^a   Pilz, Stefan ^b   Weihrauch, Gisela ^c   Seelhorst, Ursula ^d   Wellnitz, Britta ^d   Winkelmann, Bernhard R ^e   Boehm, Bernhard O ^f   März, Winfried ^b,g  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

^d LURIC Study Nonprofit LLC   (Germany)

^e Cardiology Group   (Germany)

^f UNIVERSITY OF ULM   (Germany)

^g SYNLAB ACADEMY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RESISTIN;

CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CORONARY ARTERY DISEASE; DNA POLYMORPHISM; GENOTYPE; HUMAN; LETTER; MORTALITY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR;

CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CAUSE OF DEATH; FEMALE; GENOTYPE; HUMANS; LINKAGE (GENETICS); MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RESISTIN;

EID: 47549114697     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2007.03163.x     Document Type: Letter

References (5)

1. Reilly, M.P., Lehrke, M., Wolfe, M.L., Rohatgi, A., Lazar, M.A. Rader, D.J. (2005) Resistin is an inflammatory marker of atherosclerosis in humans. Circulation, 111, 932 939.
2. Tang, N.P., Wang, L.S., Yang, L., Zhou, B., Gu, H.J., Sun, Q.M., Cong, R.H., Zhu, H.J. Wang, B. (2008) A polymorphism in the resistin gene promoter and the risk of coronary artery disease in a Chinese population. Clinical Endocrinological, 68, 82 87.
3. Winkelmann, B.R., Marz, W., Boehm, B.O., Zotz, R., Hager, J., Hellstern, P. Senges, J. (2001) Rationale and design of the LURIC study - a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease. Pharmacogenomics, 2, S1 S73.
4. Pilz, S., Weihrauch, G., Seelhorst, U., Wellnitz, B., Winkelmann, B.R., Boehm, B.O. Marz, W. (2007) Implications of resistin plasma levels in subjects undergoing coronary angiography. Clinical Endocrinological, 66, 380 386.
5. Norata, G.D., Ongari, M., Garlaschelli, K., Tibolla, G., Grigore, L., Raselli, S., Vettoretti, S., Baragetti, I., Noto, D., Cefalu, A.B., Buccianti, G., Averna, M. Catapano, A.L. (2007) Effect of the -420C/G variant of the resistin gene promoter on metabolic syndrome, obesity, myocardial infarction and kidney dysfunction. Journal of International Medicine, 262, 104 112.